Literature DB >> 18612318

Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease.

Keun-Hwa Jung1, Kon Chu, Soon-Tae Lee, Hee-Kwon Park, Dong-Hyun Kim, Jin-Hee Kim, Jae-Jun Bahn, Eun-Cheol Song, Manho Kim, Sang Kun Lee, Jae-Kyu Roh.   

Abstract

Moyamoya disease (MMD) is an unusual form of chronic cerebrovascular occlusive disease that involves the formation of characteristically abnormal vessels. Recent studies have reported that colony-forming unit (CFU) and outgrowth cells represent a subpopulation of endothelial progenitor cells (EPCs). Here, we attempted to determine the significance of CFU number and outgrowth cell yield in MMD. Endothelial progenitor cells were isolated from the blood of 24 adult MMD patients and from 48 age- and risk factor-matched control subjects. After 7 days of culture, CFUs were determined, and yields of outgrowth cells were measured during 2 months of culture. The EPC function was also evaluated using matrigel plate assays. It was found that CFU numbers were significantly lower in MMD patients than in controls. Moreover, during long-term culture, outgrowth cells were isolated from only 10% of control subjects but from 33% of MMD patients, and CFU numbers and tube formation were found to be lower in advanced MMD cases than in those with early stage disease, whereas outgrowth cells were more frequently detected in those with early MMD and moyamoya vessels than in those with advanced disease. These characteristics of circulating EPCs reflect mixed conditions of vascular occlusion and abnormal vasculogenesis during the pathogenesis of MMD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612318     DOI: 10.1038/jcbfm.2008.67

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  21 in total

Review 1.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

Review 2.  Progress in moyamoya disease.

Authors:  Shuling Shang; Da Zhou; Jingyuan Ya; Sijie Li; Qi Yang; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  Neurosurg Rev       Date:  2018-06-18       Impact factor: 3.042

Review 3.  Influence of heavy metals in Parkinson's disease: an overview.

Authors:  Balachandar Vellingiri; Atchaya Suriyanarayanan; Kripa Susan Abraham; Dhivya Venkatesan; Mahalaxmi Iyer; Neethu Raj; Abilash Valsala Gopalakrishnan
Journal:  J Neurol       Date:  2022-07-28       Impact factor: 6.682

4.  MicroRNA Expression in Circulating Leukocytes and Bioinformatic Analysis of Patients With Moyamoya Disease.

Authors:  Kaijiang Kang; Yuan Shen; Qian Zhang; Jingjing Lu; Yi Ju; Ruijun Ji; Na Li; Jianwei Wu; Bo Yang; Jinxi Lin; Xianhong Liang; Dong Zhang; Xingquan Zhao
Journal:  Front Genet       Date:  2022-05-20       Impact factor: 4.772

Review 5.  Experimental Animal Models for Moyamoya Disease: A Species-Oriented Scoping Review.

Authors:  Lei Cao; Yang Dong; Kaiwen Sun; Dongpeng Li; Hao Wang; Hongwei Li; Bo Yang
Journal:  Front Surg       Date:  2022-07-01

Review 6.  Pathological Circulating Factors in Moyamoya Disease.

Authors:  Yao-Ching Fang; Ling-Fei Wei; Chaur-Jong Hu; Yong-Kwang Tu
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

Review 7.  Moyamoya Biomarkers.

Authors:  Edward R Smith
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

Review 8.  Circulating Vascular Progenitor Cells in Moyamoya Disease.

Authors:  Hyun-Seung Kang; Kyu-Chang Wang; Seung-Ki Kim
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

Review 9.  The Pathophysiology of Moyamoya Disease: An Update.

Authors:  Oh Young Bang; Miki Fujimura; Seung-Ki Kim
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

Review 10.  Moyamoya Disease and Spectrums of RNF213 Vasculopathy.

Authors:  Oh Young Bang; Jong-Won Chung; Dong Hee Kim; Hong-Hee Won; Je Young Yeon; Chang-Seok Ki; Hyung Jin Shin; Jong-Soo Kim; Seung Chyul Hong; Duk-Kyung Kim; Akio Koizumi
Journal:  Transl Stroke Res       Date:  2019-10-24       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.